| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/28/2009 | US7524935 Sequences characteristic of hypoxia-regulated gene transcription |
| 04/28/2009 | US7524931 Full-length interferon gamma polypeptide variants |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524827 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a bcl-2 gene and the second hybridizing to a different type of oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers |
| 04/28/2009 | US7524826 Method of inhibiting the generation of active thrombin on the surface of a cell within an atherosclerotic plaque |
| 04/28/2009 | US7524674 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera |
| 04/28/2009 | US7524643 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 04/28/2009 | US7524622 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
| 04/28/2009 | US7524506 gM-negative EHV-mutants without heterologous elements |
| 04/28/2009 | US7524501 Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies |
| 04/28/2009 | US7524493 Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
| 04/28/2009 | US7524492 Insulin related transcription factor and uses thereof |
| 04/28/2009 | US7524490 Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site |
| 04/28/2009 | US7524327 Light activated gene transduction using long wavelength ultraviolet light for cell targeted gene delivery |
| 04/28/2009 | CA2283537C Vectors having enhanced expression, and methods of making and uses thereof |
| 04/28/2009 | CA2220195C Therapeutic oligonucleotides targeting the human mdr1 and mrp genes |
| 04/28/2009 | CA2212382C Cochleate delivery vehicles |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/23/2009 | WO2009052367A1 Micro- and nanoscale devices for delivery of active fibronolytic agents |
| 04/23/2009 | WO2009051801A2 Chemical inhibitors of inhibitors of differentiation |
| 04/23/2009 | WO2009051712A1 Dnai amphoteric liposome formulation |
| 04/23/2009 | WO2009051707A1 Vaccine vectors |
| 04/23/2009 | WO2009051078A1 Therapeutic gene expression system |
| 04/23/2009 | WO2009050898A1 Therapeutic agent for colorectal cancer |
| 04/23/2009 | WO2009050372A2 Compositions containing lipophosphoramides and use thereof in gene therapy |
| 04/23/2009 | WO2009049406A1 Use of ps20 /wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | WO2008074487A3 Lipids and lipid assemblies comprising transfection enhancer elements |
| 04/23/2009 | WO2007141737A3 Targeted gene expression for the treatment of primary tumors, and a therapeutic extension to the treatment of metastases. |
| 04/23/2009 | WO2007053480A3 Protein demethylases comprising a jmjc domain |
| 04/23/2009 | WO2006113540A3 Use of ntrosylated hemoglobin |
| 04/23/2009 | WO2006107387A3 Wound treatment device for photodynamic therapy and method of using same |
| 04/23/2009 | WO2006073970A3 Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |
| 04/23/2009 | WO2005097205A3 Dna virus microrna and methods for inhibiting same |
| 04/23/2009 | WO2005089443A3 Combinatorial methods and compositions for treatment of melanoma |
| 04/23/2009 | US20090105687 Scoring catheter with drug delivery membrane |
| 04/23/2009 | US20090105351 Micellar drug delivery systems for hydrophobic drugs |
| 04/23/2009 | US20090105193 Crosslinked compounds and methods of making and using thereof |
| 04/23/2009 | US20090105183 Pharmaceutical composition containing decoy and method of using the same |
| 04/23/2009 | US20090105180 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 04/23/2009 | US20090105170 Multiple Heat Shock Elements |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105148 Compositions and methods for treating myocardial infarction |
| 04/23/2009 | US20090105088 Mutant bank |
| 04/23/2009 | US20090104691 Novel recombinant adenovirus vector having a reduced side effect |
| 04/23/2009 | US20090104618 Diagnosing high grade ductal carcinoma (mammary glands) in situ (DCIS) by determining the level of psoriasin gene expression in a sample |
| 04/23/2009 | US20090104279 Use of pak inhibitor for the treatment of a joint disease |
| 04/23/2009 | US20090104245 makes it possible to add viruses as biologically active agents into a biodegradable gel so that viruses do not loose their activity to infect and/or transfect cells; for controlled delivery of biologically active agents where said biodegradable carrier is a silica xerogel |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104229 Novel use |
| 04/23/2009 | US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It |
| 04/23/2009 | US20090104198 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 04/23/2009 | US20090104182 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/23/2009 | US20090104155 Treatment of connective tissue disorders |
| 04/23/2009 | US20090104154 Composition and method for killing of tumours |
| 04/23/2009 | CA2740882A1 Use of ps20/wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | CA2702494A1 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 04/23/2009 | CA2701037A1 New lipophilic compositions and their uses |
| 04/22/2009 | EP2050818A1 Transcriptional activators with graded transactivation potential |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2049660A2 Novel glutamic acid decarboxylase (gad) proteins and methods of use |
| 04/22/2009 | EP2049158A2 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 04/22/2009 | EP2049154A1 Plasmids with immunological action |
| 04/22/2009 | EP2003140A9 Galactose derivative, drug carrier and medicinal composition |
| 04/22/2009 | EP1778297B1 Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein |
| 04/22/2009 | EP1734828A4 Genetically modified heart valve xenografts |
| 04/22/2009 | EP1554382B1 Gpr54 knock-out mammals and screening methods using them |
| 04/22/2009 | EP1468014B1 Compositions and methods for WT1 specific immunotherapy |
| 04/22/2009 | EP1379873B1 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 04/22/2009 | EP1299727B1 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/22/2009 | EP1214088B1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 04/22/2009 | EP0882134B1 Methods and compositions for protective and therapeutic genetic immunization |
| 04/22/2009 | EP0635068B2 Amplification of human mdm2 gene in human tumors |
| 04/22/2009 | CN101415817A Entrapped stem cells and uses thereof |
| 04/22/2009 | CN101415444A Biodegradable cationic polymers |
| 04/22/2009 | CN101415443A Compositions of stabilized DNA for coating microprojctions |
| 04/22/2009 | CN101415439A Glp-1 agonists, compositions, methods and uses |
| 04/22/2009 | CN100479863C Correlation of cofilin 1 and resistance to anticancer taxane chemotherapy medicine |
| 04/21/2009 | US7521433 Complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/21/2009 | US7521258 Methods of detecting, measuring, and evaluating modulators of body weight in biological samples, and diagnostic, monitoring, and therapeutic uses thereof |
| 04/21/2009 | US7521240 Chromosome-based platforms |
| 04/21/2009 | US7521239 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521177 Contacting the sample with a flavivirus antigen,produced by expressing a transcriptional unit encoding a Japanese encephalitis virus (JEV) signal sequence and an immunogenic flavivirus antigen of a flavivirus; detecting an increase in antigen/antibody complex formation |
| 04/21/2009 | US7521057 Lamprey GnRH-III polypeptides and methods of making thereof |
| 04/21/2009 | US7521043 Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines |
| 04/21/2009 | CA2341050C Nucleic acid sequence for potentiating the expression of useful gene and method therefor |
| 04/21/2009 | CA2289122C Bak promoter expression system |
| 04/21/2009 | CA2193641C 66 kda antigen from borrelia |
| 04/21/2009 | CA2182034C Treatment for juvenile diabetes |
| 04/16/2009 | WO2009047928A1 Method of producing functional dna, transformant and remedy for disease |
| 04/16/2009 | WO2009047330A1 Use of wnt5a for treating or preventing obesity and atherosclerosis |
| 04/16/2009 | WO2009046483A1 Therapeutic protocol for the treatment or prevention of thrombocytopenia |
| 04/16/2009 | WO2009018219A3 Methods and compositions for modulating rad51 and homologous recombination |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008019159A3 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 04/16/2009 | WO2007095353A3 Gpcrs as angiogenesis targets |
| 04/16/2009 | WO2007086923A3 Controlled and sustained gene transfer mediated by thiol-modified polymers |
| 04/16/2009 | WO2007063424A3 The modulation of immunity and ceacam1 activity |